MEDICÍNA PRO PRAXI / Med. Praxi. 2025;22(2):105-110 / www.medicinapropraxi.cz 110 MEZIOBOROVÉ PŘEHLEDY Transplantace střevní mikrobioty – aktuální trendy a budoucnost na Klinice infekčních chorob Fakultní nemocnice Brno v letech 2010–2014 – prospektivní studie. Epidemiol Mikrobiol Imunol. 2015;64(4). 27. Tariq R, Pardi DS, Bartlett MG, et al. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta‑analysis. Clin Infect, DiS. 2019 Apr 8;68(8):1351-8. 28. Hui W, Li T, Liu W, et al. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta‑analysis. Cheungpasitporn W, editor. PLOS ONE. 2019 Jan 23;14(1):e0210016. 29. Allegretti JR, Fischer M, Sagi SV, et al. Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose. Dig Dis Sci. 2019 Jun;64(6):1672-8. 30. Moayyedi P, Surette MG, Kim PT, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015 Jul;149(1):102-109.e6. 31. Rossen NG, Fuentes S, Van Der Spek MJ, et al. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology. 2015 Jul;149(1):110-118.e4. 32. Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial. Hepatology. 2017 Dec;66(6):1727-38. 33. Dinh A, Fessi H, Duran C, et al. Clearance of carbapenem‑resistant Enterobacteriaceae vs vancomycin ‑resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. J Hosp Infect. 2018 Aug;99(4):481-6. SDĚLENÍ Z PRAXE PRIESKUM INFORMOVANOSTI SENIORSKEJ POPULÁCIE O PREVENCII CHRÍPKY Prieskum informovanosti seniorskej populácie o prevencii chrípky PhDr. Iveta Ondriová, PhD. Katedra ošetrovateľstva FZOPU v Prešove Chrípka je infekčné ochorenie, ktoré vyvoláva rýchlo sa šíriaci a premenlivý vírus. Prebieha ako celkové zápalové ochorenie horných dýchacích ciest. Nástup chrípky je náhly, pri plnom zdraví. Komplikácie sa vyskytujú zvlášť u vysokorizikových osôb (starých ľudí a ľudí trpiacich na chronické ochorenie srdca) a zomrieť na následky chrípky môže aj dovtedy úplne zdravý človek. Cieľom príspevku bolo monitorovať informovanosť seniorov v oblasti preventívnych opatrení proti chrípke. Prieskumnú vzorku tvorilo 100 respondentov mužského a ženského pohlavia vo veku nad 61 rokov. Ako metódu pre zber dát sme zvolili neštandardizovaný dotazník. Kľúčové slová: zdravie, informovanosť, chrípka, seniori. A survey of the awareness of the senior population about influenza prevention Influenza is an infectious disease caused by a rapidly spreading and mutable virus. It occurs as a general inflammatory disease of the upper respiratory tract. The onset of influenza is sudden, in full health. Complications occur especially in high-risk individuals (elderly people and people suffering from chronic heart disease) and even a completely healthy person can die from the consequences of influenza. The aim of the paper was to monitor the awareness of seniors in the field of influenza preventive measures. The survey sample consisted of 100 male and female respondents over the age of 61. We chose a non-standardized questionnaire as the method for data collection. Key words: health, awareness, influenza, seniors. Úvod kontaminovaných predmetov (kľučky, telefóDECLARATIONS: Declaration of originality: The manuscript is original and has not been published or submitted elsewhere. Ethical principles compliance: The authors attest that their study was approved by the local Ethical Committee and is in compliance with human studies and animal welfare regulations of the authors’ institutions as well as with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects adopted by the 18th WMA General Assembly in Helsinki, Finland, in June 1964, with subsequent amendments, as well as with the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, updated in December 2018, including patient consent where appropriate. Conflict of interest: Not applicable. Consent for publication: Not applicable. PLNÁ VERZE ČLÁNKU ➜ https://doi.org/10.36290/med.2025.016
RkJQdWJsaXNoZXIy NDA4Mjc=